ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $0 | -100.0% | 100 | -99.3% | 0.00% | -100.0% |
Q1 2018 | $40,000 | -2.4% | 14,956 | +27.0% | 0.00% | -40.0% |
Q4 2017 | $41,000 | +1950.0% | 11,777 | +948.7% | 0.01% | – |
Q4 2016 | $2,000 | -50.0% | 1,123 | -25.6% | 0.00% | – |
Q3 2016 | $4,000 | -50.0% | 1,509 | -48.2% | 0.00% | -100.0% |
Q2 2016 | $8,000 | – | 2,911 | +291000.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 1 | -99.9% | 0.00% | -100.0% |
Q3 2015 | $12,000 | +1100.0% | 1,215 | +1520.0% | 0.00% | – |
Q2 2015 | $1,000 | – | 75 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |